Insider Transactions in Q4 2024 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2024
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+32.68%
|
-
|
|
Dec 27
2024
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,345
-6.4%
|
-
|
|
Dec 27
2024
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,667
+15.39%
|
-
|
|
Dec 27
2024
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,839
-14.37%
|
-
|
|
Dec 27
2024
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,667
+24.49%
|
-
|
|
Dec 27
2024
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.3%
|
-
|
|
Dec 27
2024
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,941
-1.06%
|
-
|
|
Dec 27
2024
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,667
+3.51%
|
-
|
|
Dec 27
2024
|
Richard J Daly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
324
-0.14%
|
-
|
|
Dec 27
2024
|
Richard J Daly President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.56%
|
-
|
|
Dec 27
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,541
-5.46%
|
-
|
|
Dec 27
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+12.19%
|
-
|
|
Dec 27
2024
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.38%
|
-
|
|
Dec 27
2024
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,333
+0.18%
|
-
|
|
Dec 27
2024
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+1.47%
|
-
|
|
Dec 13
2024
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
235,000
+20.31%
|
$940,000
$4.01 P/Share
|
|
Dec 10
2024
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+5.21%
|
$160,000
$4.01 P/Share
|
|
Dec 10
2024
|
Steve Miller Chief Op. & Scientific Officer |
SELL
Open market or private sale
|
Direct |
50,000
-6.78%
|
$1,050,000
$21.93 P/Share
|
|
Dec 10
2024
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+6.35%
|
$200,000
$4.01 P/Share
|
|
Dec 09
2024
|
Jeffrey Del Carmen Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,355
-11.54%
|
-
|
|
Dec 09
2024
|
Jeffrey Del Carmen Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,039
+28.26%
|
-
|
|
Dec 09
2024
|
Preethi Sundaram Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,415
-7.45%
|
-
|
|
Dec 09
2024
|
Preethi Sundaram Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,855
+17.46%
|
-
|
|
Dec 09
2024
|
Donald A Denkhaus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+0.32%
|
-
|
|
Dec 09
2024
|
Charles B O'Keeffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+0.21%
|
-
|
|
Dec 09
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,533
+0.08%
|
-
|
|
Dec 09
2024
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+50.0%
|
-
|
|
Dec 09
2024
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,720
-0.97%
|
-
|
|
Dec 09
2024
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,067
+3.81%
|
-
|
|
Dec 09
2024
|
David S Tierney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+0.4%
|
-
|
|
Dec 09
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,891
-4.92%
|
-
|
|
Dec 09
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,349
+11.12%
|
-
|
|
Dec 09
2024
|
Tamar Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+50.0%
|
-
|
|
Dec 09
2024
|
Steve Miller Chief Op. & Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,872
+1.7%
|
-
|
|
Nov 27
2024
|
Molly Harper Director |
SELL
Open market or private sale
|
Direct |
17,500
-100.0%
|
$385,000
$22.0 P/Share
|
|
Nov 27
2024
|
Molly Harper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+50.0%
|
$87,500
$5.78 P/Share
|
|
Nov 27
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
12,000
-9.88%
|
$264,000
$22.71 P/Share
|
|
Nov 27
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+15.92%
|
$48,000
$4.01 P/Share
|
|
Nov 26
2024
|
Brian Elsbernd Chief Compliance/Legal Officer |
SELL
Open market or private sale
|
Direct |
13,256
-3.79%
|
$278,376
$21.62 P/Share
|
|
Nov 26
2024
|
Brian Elsbernd Chief Compliance/Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+13.81%
|
$240,000
$4.01 P/Share
|
|
Nov 20
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
38,000
-42.51%
|
$798,000
$21.2 P/Share
|
|
Nov 20
2024
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,000
+29.83%
|
$152,000
$4.01 P/Share
|
|
Nov 20
2024
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
72,500
-1.59%
|
$1,522,500
$21.29 P/Share
|
|
Nov 20
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72,500
+1.57%
|
$217,500
$3.54 P/Share
|
|
Nov 19
2024
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
98,345
-2.15%
|
$2,065,245
$21.19 P/Share
|
|
Nov 19
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,345
+2.1%
|
$295,035
$3.54 P/Share
|
|
Nov 14
2024
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
44,655
-0.99%
|
$937,755
$21.75 P/Share
|
|
Nov 14
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
44,655
+0.98%
|
$133,965
$3.54 P/Share
|
|
Nov 13
2024
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
92,500
-2.02%
|
$2,035,000
$22.98 P/Share
|
|
Nov 13
2024
|
Patrick J Mcenany Director |
BUY
Exercise of conversion of derivative security
|
Direct |
92,500
+1.98%
|
$277,500
$3.54 P/Share
|